Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment

Ha Thi Nguyen, Mitsuaki Ono, Yasutaka Oida, Emilio satoshi Hara, Taishi Komori, Kentaro Akiyama, Ha Thi Thu Nguyen, Kyaw Thu Aung, Hai Thanh Pham, Ikue Tosa, Takeshi Takarada, Koichi Matsuo, Toshihide Mizoguchi, Toshitaka Oohashi, Takuo Kuboki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Bone morphogenetic protein 2 (BMP-2) is widely known as a potent growth factor that promotes bone formation. However, an increasing number of studies have demonstrated side effects of BMP-2 therapy. A deeper understanding of the effect of BMP-2 on cells other than those involved directly in bone remodeling is of fundamental importance to promote a more effective delivery of BMP-2 to patients. In this study, we aimed to investigate the effect of BMP-2 in the marrow environment. First, BMP-2 adsorbed onto titanium implants was delivered at the tooth extraction socket (marrow-absent site) or in the mandible marrow of beagle dogs. BMP-2 could induce marked bone formation around the implant at the tooth extraction socket. Surprisingly, however, no bone formation was observed in the BMP-2-coated titanium implants inserted in the mandible marrow. In C57BL/6 mice, BMP-2 adsorbed in freeze-dried collagen pellets could induce bone formation in marrow-absent calvarial bone. However, similar to the canine model, BMP-2 could not induce bone formation in the femur marrow. Analysis of osteoblast differentiation using Col1a1(2.3)-GFP transgenic mice revealed a scarce number of osteoblasts in BMP-2-treated femurs, whereas in the control group, osteoblasts were abundant. Ablation of femur marrow recovered the BMP-2 ability to induce bone formation. In vitro experiments analyzing luciferase activity of C2C12 cells with the BMP-responsive element and alkaline phosphatase activity of MC3T3-E1 osteoblasts further revealed that bone marrow cells inhibit the BMP-2 effect on osteoblasts by direct cell–cell contact. Collectively, these results showed that the effect of BMP-2 in inducing bone formation is remarkably repressed by marrow cells via direct cell–cell contact with osteoblasts; this opens new perspectives on the clarification of the side-effects associated with BMP-2 application.

Original languageEnglish
JournalJournal of Bone and Mineral Research
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Bone Morphogenetic Protein 2
Osteoblasts
Bone Marrow Cells
Bone Marrow
Osteogenesis
Tooth Socket
Femur
Tooth Extraction
Titanium
Mandible
Bone Remodeling
Luciferases
Inbred C57BL Mouse
Transgenic Mice
Alkaline Phosphatase

Keywords

  • BMP-2
  • BONE MARROW
  • ORAL IMPLANT
  • OSTEOBLASTOGENESIS

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment. / Nguyen, Ha Thi; Ono, Mitsuaki; Oida, Yasutaka; Hara, Emilio satoshi; Komori, Taishi; Akiyama, Kentaro; Nguyen, Ha Thi Thu; Aung, Kyaw Thu; Pham, Hai Thanh; Tosa, Ikue; Takarada, Takeshi; Matsuo, Koichi; Mizoguchi, Toshihide; Oohashi, Toshitaka; Kuboki, Takuo.

In: Journal of Bone and Mineral Research, 01.01.2018.

Research output: Contribution to journalArticle

Nguyen, Ha Thi ; Ono, Mitsuaki ; Oida, Yasutaka ; Hara, Emilio satoshi ; Komori, Taishi ; Akiyama, Kentaro ; Nguyen, Ha Thi Thu ; Aung, Kyaw Thu ; Pham, Hai Thanh ; Tosa, Ikue ; Takarada, Takeshi ; Matsuo, Koichi ; Mizoguchi, Toshihide ; Oohashi, Toshitaka ; Kuboki, Takuo. / Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment. In: Journal of Bone and Mineral Research. 2018.
@article{afe237b1bbe24c30900186a1ddb3b345,
title = "Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment",
abstract = "Bone morphogenetic protein 2 (BMP-2) is widely known as a potent growth factor that promotes bone formation. However, an increasing number of studies have demonstrated side effects of BMP-2 therapy. A deeper understanding of the effect of BMP-2 on cells other than those involved directly in bone remodeling is of fundamental importance to promote a more effective delivery of BMP-2 to patients. In this study, we aimed to investigate the effect of BMP-2 in the marrow environment. First, BMP-2 adsorbed onto titanium implants was delivered at the tooth extraction socket (marrow-absent site) or in the mandible marrow of beagle dogs. BMP-2 could induce marked bone formation around the implant at the tooth extraction socket. Surprisingly, however, no bone formation was observed in the BMP-2-coated titanium implants inserted in the mandible marrow. In C57BL/6 mice, BMP-2 adsorbed in freeze-dried collagen pellets could induce bone formation in marrow-absent calvarial bone. However, similar to the canine model, BMP-2 could not induce bone formation in the femur marrow. Analysis of osteoblast differentiation using Col1a1(2.3)-GFP transgenic mice revealed a scarce number of osteoblasts in BMP-2-treated femurs, whereas in the control group, osteoblasts were abundant. Ablation of femur marrow recovered the BMP-2 ability to induce bone formation. In vitro experiments analyzing luciferase activity of C2C12 cells with the BMP-responsive element and alkaline phosphatase activity of MC3T3-E1 osteoblasts further revealed that bone marrow cells inhibit the BMP-2 effect on osteoblasts by direct cell–cell contact. Collectively, these results showed that the effect of BMP-2 in inducing bone formation is remarkably repressed by marrow cells via direct cell–cell contact with osteoblasts; this opens new perspectives on the clarification of the side-effects associated with BMP-2 application.",
keywords = "BMP-2, BONE MARROW, ORAL IMPLANT, OSTEOBLASTOGENESIS",
author = "Nguyen, {Ha Thi} and Mitsuaki Ono and Yasutaka Oida and Emilio satoshi Hara and Taishi Komori and Kentaro Akiyama and Nguyen, {Ha Thi Thu} and Aung, {Kyaw Thu} and Pham, {Hai Thanh} and Ikue Tosa and Takeshi Takarada and Koichi Matsuo and Toshihide Mizoguchi and Toshitaka Oohashi and Takuo Kuboki",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jbmr.3598",
language = "English",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment

AU - Nguyen, Ha Thi

AU - Ono, Mitsuaki

AU - Oida, Yasutaka

AU - Hara, Emilio satoshi

AU - Komori, Taishi

AU - Akiyama, Kentaro

AU - Nguyen, Ha Thi Thu

AU - Aung, Kyaw Thu

AU - Pham, Hai Thanh

AU - Tosa, Ikue

AU - Takarada, Takeshi

AU - Matsuo, Koichi

AU - Mizoguchi, Toshihide

AU - Oohashi, Toshitaka

AU - Kuboki, Takuo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Bone morphogenetic protein 2 (BMP-2) is widely known as a potent growth factor that promotes bone formation. However, an increasing number of studies have demonstrated side effects of BMP-2 therapy. A deeper understanding of the effect of BMP-2 on cells other than those involved directly in bone remodeling is of fundamental importance to promote a more effective delivery of BMP-2 to patients. In this study, we aimed to investigate the effect of BMP-2 in the marrow environment. First, BMP-2 adsorbed onto titanium implants was delivered at the tooth extraction socket (marrow-absent site) or in the mandible marrow of beagle dogs. BMP-2 could induce marked bone formation around the implant at the tooth extraction socket. Surprisingly, however, no bone formation was observed in the BMP-2-coated titanium implants inserted in the mandible marrow. In C57BL/6 mice, BMP-2 adsorbed in freeze-dried collagen pellets could induce bone formation in marrow-absent calvarial bone. However, similar to the canine model, BMP-2 could not induce bone formation in the femur marrow. Analysis of osteoblast differentiation using Col1a1(2.3)-GFP transgenic mice revealed a scarce number of osteoblasts in BMP-2-treated femurs, whereas in the control group, osteoblasts were abundant. Ablation of femur marrow recovered the BMP-2 ability to induce bone formation. In vitro experiments analyzing luciferase activity of C2C12 cells with the BMP-responsive element and alkaline phosphatase activity of MC3T3-E1 osteoblasts further revealed that bone marrow cells inhibit the BMP-2 effect on osteoblasts by direct cell–cell contact. Collectively, these results showed that the effect of BMP-2 in inducing bone formation is remarkably repressed by marrow cells via direct cell–cell contact with osteoblasts; this opens new perspectives on the clarification of the side-effects associated with BMP-2 application.

AB - Bone morphogenetic protein 2 (BMP-2) is widely known as a potent growth factor that promotes bone formation. However, an increasing number of studies have demonstrated side effects of BMP-2 therapy. A deeper understanding of the effect of BMP-2 on cells other than those involved directly in bone remodeling is of fundamental importance to promote a more effective delivery of BMP-2 to patients. In this study, we aimed to investigate the effect of BMP-2 in the marrow environment. First, BMP-2 adsorbed onto titanium implants was delivered at the tooth extraction socket (marrow-absent site) or in the mandible marrow of beagle dogs. BMP-2 could induce marked bone formation around the implant at the tooth extraction socket. Surprisingly, however, no bone formation was observed in the BMP-2-coated titanium implants inserted in the mandible marrow. In C57BL/6 mice, BMP-2 adsorbed in freeze-dried collagen pellets could induce bone formation in marrow-absent calvarial bone. However, similar to the canine model, BMP-2 could not induce bone formation in the femur marrow. Analysis of osteoblast differentiation using Col1a1(2.3)-GFP transgenic mice revealed a scarce number of osteoblasts in BMP-2-treated femurs, whereas in the control group, osteoblasts were abundant. Ablation of femur marrow recovered the BMP-2 ability to induce bone formation. In vitro experiments analyzing luciferase activity of C2C12 cells with the BMP-responsive element and alkaline phosphatase activity of MC3T3-E1 osteoblasts further revealed that bone marrow cells inhibit the BMP-2 effect on osteoblasts by direct cell–cell contact. Collectively, these results showed that the effect of BMP-2 in inducing bone formation is remarkably repressed by marrow cells via direct cell–cell contact with osteoblasts; this opens new perspectives on the clarification of the side-effects associated with BMP-2 application.

KW - BMP-2

KW - BONE MARROW

KW - ORAL IMPLANT

KW - OSTEOBLASTOGENESIS

UR - http://www.scopus.com/inward/record.url?scp=85055513545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055513545&partnerID=8YFLogxK

U2 - 10.1002/jbmr.3598

DO - 10.1002/jbmr.3598

M3 - Article

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

ER -